In utero exposure to medroxyprogesterone.
Brundage
S C
SC
D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011258:Pregnancy Tests; D011297:Prenatal Exposure Delayed Effects
D008525:Medroxyprogesterone